SNHG6 and cancer: Subsequently, we comprehensively analyzed the effects of SNHG6 on overall survival (OS), DSS, disease-free interval (DFI), and progression-free interval (PFI) of cancer patients, and the results showed that upregulation of SNHG6 may be detrimental to the prognosis of KIRP patients.